Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Lovastatin products are in shortage in Canada (2 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A statin used to lower cholesterol and reduce the risk of heart disease.
Products affected
2 / 10
In shortage since
Sep 1, 2018
Reports on file
19
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ACT LOVASTATIN
40MG · TABLET · ACTAVIS PHARMA COMPANY
DIN 02248573 · since Sep 1, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACT LOVASTATIN
20MG · TABLET · ACTAVIS PHARMA COMPANY
DIN 02248572 · since Sep 1, 2018, no end estimate · Disruption of the manufacture of the drug.
Resolved
LOVASTATIN
20MG · TABLET · AA PHARMA INC
DIN 02220172 · ended May 26, 2026 · Disruption of the manufacture of the drug.
Resolved
LOVASTATIN
40MG · TABLET · AA PHARMA INC
DIN 02220180 · ended Apr 29, 2025 · Disruption of the manufacture of the drug.
Resolved
LOVASTATIN
40MG · TABLET · SANIS HEALTH INC
DIN 02353237 · ended Mar 1, 2024 · Disruption of the manufacture of the drug.
Resolved
LOVASTATIN
20MG · TABLET · SANIS HEALTH INC
DIN 02353229 · ended Mar 1, 2024 · Disruption of the manufacture of the drug.
Resolved
LOVASTATIN
20MG · TABLET · SANIS HEALTH INC
DIN 02353229 · ended Jul 25, 2019 · Disruption of the manufacture of the drug.
Discontinued
APO-LOVASTATIN - TAB 20MG
20MG · TABLET · APOTEX INC
DIN 02220172
Resolved
APO-LOVASTATIN - TAB 20MG
20MG · TABLET · APOTEX INC
DIN 02220172 · ended Sep 10, 2018 · Disruption of the manufacture of the drug.
Resolved
APO-LOVASTATIN - TAB 40MG
40MG · TABLET · APOTEX INC
DIN 02220180 · ended Aug 21, 2018 · Disruption of the manufacture of the drug.
Discontinued
PRO-LOVASTATIN
20MG · TABLET · PRO DOC LIMITEE
DIN 02312670
Discontinued
PRO-LOVASTATIN
40MG · TABLET · PRO DOC LIMITEE
DIN 02312689
Showing 12 of 19 reports. All reports are on file with Health Canada.
What's happening
Lovastatin is currently affected by 2 active shortage reports filed with Health Canada by ACTAVIS PHARMA COMPANY.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Lovastatin is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AA).
Recent changes
No changes recorded yet.
Common questions
What is Lovastatin used for?
A statin used to lower cholesterol and reduce the risk of heart disease.
When will Lovastatin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Lovastatin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.